Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)

Jeongah Kim; Inah Park; Sangwon Jang; Mijung Choi; Doyeon Kim; Woong Sun; Youngshik Choe; Ji Woong Choi; Cheil Moon; Sung Ho Park; Han Kyoung Choe; Kyungjin Kim

doi:10.1007/s13311-022-01234-7

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)

Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim

Department of Biomedical Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The article “Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease”, written by Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji-Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim was originally published electronically on the publisher’s internet portal on 23 March 2022 without open access.

Original language	English
Pages (from-to)	1432
Number of pages	1
Journal	Neurotherapeutics
Volume	19
Issue number	4
DOIs	https://doi.org/10.1007/s13311-022-01234-7
Publication status	Published - 2022 Jul

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

ASJC Scopus subject areas

Pharmacology
Clinical Neurology
Pharmacology (medical)

Access to Document

10.1007/s13311-022-01234-7

Fingerprint

Dive into the research topics of 'Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)'. Together they form a unique fingerprint.

Cite this

Kim, J., Park, I., Jang, S., Choi, M., Kim, D., Sun, W., Choe, Y., Choi, J. W., Moon, C., Park, S. H., Choe, H. K., & Kim, K. (2022). Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w). Neurotherapeutics, 19(4), 1432. https://doi.org/10.1007/s13311-022-01234-7

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w). / Kim, Jeongah; Park, Inah; Jang, Sangwon et al.
In: Neurotherapeutics, Vol. 19, No. 4, 07.2022, p. 1432.

Research output: Contribution to journal › Comment/debate › peer-review

Kim, J, Park, I, Jang, S, Choi, M, Kim, D, Sun, W, Choe, Y, Choi, JW, Moon, C, Park, SH, Choe, HK & Kim, K 2022, 'Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)', Neurotherapeutics, vol. 19, no. 4, pp. 1432. https://doi.org/10.1007/s13311-022-01234-7

@article{dab614f8b4bc4aab811c2c3c39d772dd,

title = "Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson{\textquoteright}s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)",

abstract = "The article “Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson{\textquoteright}s Disease”, written by Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji-Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim was originally published electronically on the publisher{\textquoteright}s internet portal on 23 March 2022 without open access.",

author = "Jeongah Kim and Inah Park and Sangwon Jang and Mijung Choi and Doyeon Kim and Woong Sun and Youngshik Choe and Choi, {Ji Woong} and Cheil Moon and Park, {Sung Ho} and Choe, {Han Kyoung} and Kyungjin Kim",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = jul,

doi = "10.1007/s13311-022-01234-7",

language = "English",

volume = "19",

pages = "1432",

journal = "Neurotherapeutics",

issn = "1933-7213",

publisher = "Springer New York",

number = "4",

}

TY - JOUR

T1 - Correction to

T2 - Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)

AU - Kim, Jeongah

AU - Park, Inah

AU - Jang, Sangwon

AU - Choi, Mijung

AU - Kim, Doyeon

AU - Sun, Woong

AU - Choe, Youngshik

AU - Choi, Ji Woong

AU - Moon, Cheil

AU - Park, Sung Ho

AU - Choe, Han Kyoung

AU - Kim, Kyungjin

PY - 2022/7

Y1 - 2022/7

N2 - The article “Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease”, written by Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji-Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim was originally published electronically on the publisher’s internet portal on 23 March 2022 without open access.

AB - The article “Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease”, written by Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji-Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim was originally published electronically on the publisher’s internet portal on 23 March 2022 without open access.

UR - http://www.scopus.com/inward/record.url?scp=85129227591&partnerID=8YFLogxK

U2 - 10.1007/s13311-022-01234-7

DO - 10.1007/s13311-022-01234-7

M3 - Comment/debate

C2 - 35499682

AN - SCOPUS:85129227591

SN - 1933-7213

VL - 19

SP - 1432

JO - Neurotherapeutics

JF - Neurotherapeutics

IS - 4

ER -

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 19, 2, (592-607), 10.1007/s13311-022-01215-w)

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this